Prevention of viral hepatitis in Italy

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 4092-4096

  FitzSimons, David ^a   François, Guido ^b   Bonanni, Paolo ^c   Mele, Alfonso ^d   Zanetti, Alessandro ^e   Stroffolini, Tommaso ^d   Crovari, Pietro ^f   Van Damme, Pierre ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF FLORENCE   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Blood safety; Epidemiology; Health system; Italy; Lessons learnt; Prevention; Surveillance; VHPB; Viral hepatitis

Indexed keywords

VIRUS VACCINE;

EUROPE; EVALUATION; HEALTH CARE; HEPATITIS A; HEPATITIS C; HEPATITIS E; HUMAN; INDUSTRIALIZATION; ITALY; LEARNING; PRIORITY JOURNAL; REVIEW; VIRUS HEPATITIS;

EID: 4444378790     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.03.051     Document Type: Article

References (25)

1. Steffen M., Les Etats face au Sida en Europe. Grenoble, France: Presses Universitaires de Grenoble, 2001.
2. Bonanni P., Crovari P. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy. Vaccine. 16(Suppl):1998;S38-S42
3. Spada E., Mele A., Ciccozzi M., Tosti M.E., Bianco E., Szklo A., et al. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Digest Liver Dis. 33:2001;778-784
4. Coppola R.C., Masia G., Romanò L., Tanzi E., Zanetti A.R. Epidemiology and prevention of enterically transmitted hepatitis in Italy. Res. Virol. 149:1998;271-276
5. Mele A, Stroffolini T, Gallo G, Ragni P, Balocchini EF, Tosti ME and the SEIEVA Collaborating Group. Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. J. Hepatol. 1997;26:743-7.
6. Panà A., Franco E. The epidemiology of hepatitis A in Italy. Res. Virol. 146:1995;249-252
7. Lopalco P.L., Salleras L., Barbuti S., Germinario C., Bruguera M., Buti M., et al. Hepatitis A and B in children and adolescents - what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine. 19:2001;470-474
8. Bonanni P., Colombai R., Franchi G., Lo Nostro A., Comodo N., Tiscione E. Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. Epidemiol. Infect. 121:1998;377-380
9. Sagliocca L., Amoroso P., Stroffolini T., Adamo B., Tosti M.E., Lettieri G., et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomized trial. Lancet. 353:1999;1136-1139
10. Zanetti A.R., Schlauder G.G., Romanò L., Tanzi E., Fabris P., Dawson G.J., et al. Identification of a novel variant of hepatitis E virus in Italy. J. Med. Virol. 57:1999;356-360
11. Mele A., Stroffolini T., Zanetti A.R. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. J. Med. Virol. 67:2002;440-443
12. Rizzetto M., Zanetti A.R. Progress in the prevention and control of viral hepatitis type B: closing remarks. J. Med. Virol. 67:2002;463-466
13. Crovari P. Epidemiology of viral hepatitis B in Italy. Vaccine. 13(Suppl 1):1995;S26-S30
14. Bonanni P., Pesavento G., Bechini A., Tiscione E., Mannelli F., Benucci C., et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine. 21:2003;685-691
15. Gaeta G.B., Stroffolini T., Chiaramonte M., Ascione T., Stornaiuolo G., Lobello S., et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology. 32:2000;824-827
16. Stroffolini T., Mele A., Tosti M.E., Gallo G., Balocchini E., Ragni P., et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J. Hepatol. 33:2000;980-985
17. Mele A., Tancredi F., Romanò L., Giuseppone A., Colucci M., Sangiuolo A., et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J. Infect. Dis. 184:2001;905-908
18. Kondili L.A., Chionne P., Costantino A., Villano U., Lo Noce C., Pannozzo F., et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut. 50:2002;693-696
19. Velati C., Romanò L., Baruffi L., Pappalettera M., Carreri V., Zanetti A.R. Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy. Transfusion. 42:2002;989-993
20. EASL International Consensus Conference on Hepatitis C. Consensus statement, J Hepatol 1999;30:956-61.
21. Mele A., Spada E., Sagliocca L., Ragni P., Tosti M.E., Gallo G., et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J. Hepatol. 35:2001;284-289
22. Zanetti A.R., Tanzi E., Paccagnini S., Principi N., Pizzocolo G., Caccamo M.L., et al. The Lombardy Study Group On Vertical HCV Transmission Mother-to-infant transmission of hepatitis C virus. Lancet. 345:1995;289-290
23. De Paschale M., Casiraghi M.A., Biagiotti S., Rossi U., Zanetti A.R. Association between neonatal blood microtransfusions in the 1960s and hepatitis C virus infection. Lancet. 356:2000;1572-1573
24. Jackson B.R., Busch M.P., Stramer S.L., AuBuchon J.P. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion. 43:2003;721-729
25. Zanetti A.R., Romanò L. Evolving epidemiology of viral hepatitis in Italy. Digest Liver Dis. 33:2001;740-742